Linked Data API

Show Search Form

Search Results

516972
unstar this property registered interest false remove filter
star this property date less than 2016-05-03more like thismore than 2016-05-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Olympic Games: Brazil more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government, further to the Written Answers by Lord Prior of Brampton on 11 and 12 February (HL5764 and HL5766) and by Baroness Neville-Rolfe on 11 February (HL5765), and in the light of current information about the increased extent of dangers from the Zika virus affecting up to 20 per cent of all births, whether they intend to issue further advice about, or to reconsider, in consultation with other European governments, the long-term implications of participating in or attending the 2016 Olympic Games in Brazil. more like this
star this property tabling member printed
Lord Maginnis of Drumglass more like this
unstar this property uin HL8128 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-05-11more like thismore than 2016-05-11
star this property answer text <p>The British Olympic Association (BOA) and British Paralympic Association (BPA) have prepared guidance to consider the health risks, including those posed by Zika, for British athletes and staff travelling to Brazil for the Olympics.</p><p> </p><p>The Department of Health has convened an Olympics health advisory group on behalf of the Department for Culture, Media and Sport to focus on Zika and to support the BOA and BPA to ensure that they can continue to provide the best possible information and advice.</p><p> </p><p>The group will be chaired by the Department’s Chief Scientific Advisor, Professor Chris Whitty, and will bring together experts from the BOA and BPA as well as the London School of Hygiene and Tropical Medicine, University of Liverpool, University of Nottingham, the Royal Free London, Public Health England and across Government.</p><p> </p><p>Revisions of existing guidance or specific further advice will be published if it is deemed necessary.</p><p> </p><p>In the meantime, Public Health England and the National Travel Health Network and Centre (NaTHNaC) have developed and issued more general travel advice online to health professionals that is suitable for people travelling to Zika-affected countries, including pregnant women. A copy of the online advice is attached.</p><p> </p><p>This includes a list of countries where Zika virus transmission is occurring, advice around bite avoidance measures and what and who to speak to if those travelling have concerns. PHE and NaTHNaC continue to monitor the situation very closely and update advice as needed.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-05-11T16:20:48.91Zmore like thismore than 2016-05-11T16:20:48.91Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property attachment
1
star this property file name zika-virus-update-and-advice-for-travellers-including-pregnant-women.pdf more like this
star this property title Zika Virus travel advice more like this
star this property tabling member
648
star this property label Biography information for Lord Maginnis of Drumglass more like this
621149
unstar this property registered interest false remove filter
star this property date less than 2016-10-25more like thismore than 2016-10-25
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Disability: Employment Schemes more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the case for more resources to be made available for specialist support models for people with complex support needs, and who do not benefit from the Work and Health Programme. more like this
star this property tabling member printed
Baroness Garden of Frognal more like this
unstar this property uin HL2666 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-11-08more like thismore than 2016-11-08
star this property answer text <p>The Government recognises the challenges of helping those with the most complex health conditions move closer to work. The new Personal Support Package announced in <em>Improving Lives: The Work, Health and Disability </em>Green Paper introduces a range of new measures and interventions designed as part of a package of support which can be tailored to people’s individual needs. The offer, which applies to all Employment and Support Allowance claimants (and Universal Credit equivalents), includes personal support from disability trained, accredited work coaches, with a focus on mental health. Work coaches will be supported by an additional 300 Disability Employment Advisers and around 200 new community partners with disability expertise and local knowledge. This will lead to better signposting to other local voluntary and public sector services that may be available. A copy of the Green Paper is attached.</p><p> </p><p>The Government recognises that more needs to be done to help people stay well at work, including those with complex health conditions. The consultation on the Green Paper will help us to consider appropriate new models of support to help more people with disabilities or long term conditions to enter and remain in work.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-11-08T15:08:55.477Zmore like thismore than 2016-11-08T15:08:55.477Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property attachment
1
star this property file name work-and-health-green-paper-print-version.pdf more like this
star this property title HL2666 Green Paper more like this
star this property tabling member
3842
star this property label Biography information for Baroness Garden of Frognal more like this
450641
unstar this property registered interest false remove filter
star this property date less than 2016-02-04more like thismore than 2016-02-04
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Accident and Emergency Departments more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what steps they are taking to develop the model of co-location of urgent and emergency primary care service with accident and emergency departments. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
unstar this property uin HL5942 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-02-11more like thismore than 2016-02-11
star this property answer text <p>In August 2015, NHS England published <em>Safer, faster, better: good practice in delivering urgent and emergency care. </em>A copy is attached. This provides guidance to help frontline providers and commissioners re-design urgent and emergency care services, including considering locating urgent care centres in emergency departments.</p><p><em>Safer, faster, better</em> notes that urgent care centres co-located with emergency departments provide an opportunity to stream patients with less serious illnesses and injuries to a service that is resourced to meet their needs, while reducing crowding in emergency departments. It also sets out that to preserve flow, urgent care centre staff and cubicles must wherever possible be entirely separated from the majors/admission stream and that where urgent care centres are co-located with emergency departments, there must be appropriate integration, with shared governance arrangements and clearly defined protocols for the two-way transfer of patients.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-02-11T12:53:09.36Zmore like thismore than 2016-02-11T12:53:09.36Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property attachment
1
star this property file name trans-uec - HL5942.pdf more like this
star this property title Safer, Faster, Better more like this
star this property tabling member
1850
star this property label Biography information for Baroness Masham of Ilton more like this
421268
unstar this property registered interest false remove filter
star this property date less than 2015-10-14more like thismore than 2015-10-14
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Hypothyroidism more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what steps they have taken to help patients with undiagnosed hypothyroidism who present clinical signs and symptoms of that condition, but are refused any treatment as their blood test results remain normal. more like this
star this property tabling member printed
Lord Pendry more like this
unstar this property uin HL2639 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-10-27more like thismore than 2015-10-27
star this property answer text <p>A blood test measuring hormone levels is the only accurate way to find out if there is a thyroid problem.</p><br /><p>Best practice on the identification and management of hypothyroidism has been set out by the Royal College of Physicians (RCP) in its guidance, <em>The Diagnosis and Management of Primary Hypothyroidism</em>, first published in 2008. The guidance, which is attached, was developed on behalf of key organisations, including the British Thyroid Association (BTA), the British Thyroid Foundation (BTF) and the Society for Endocrinology (SOE), and is endorsed by the Royal College of General Practitioners. A copy of the UK Guidelines is attached.</p><br /><p>The RCP guidance sets out that the only validated method of testing thyroid function is through a blood sample, which must include measurement of the levels of thyroid‐stimulating hormone (TSH) and free thyroxine (FT4) in serum, as recommended in the <em>UK Guidelines for the Use of Thyroid Function Tests</em> published by the BTA.</p><br /><p>The RCP guidelines set out that overwhelming evidence supports the use of thyroxine hormone replacement (T4 or tetra-iodothyronine) alone in the treatment of hypothyroidism, with this usually being prescribed as levothyroxine. However, this does not prevent clinicians considering other forms of thyroid hormone replacement if appropriate.</p><p>The guidance remains up-to-date and a statement from the BTA Executive Committee supporting the existing guidelines was published in May 2015 in <em>Clinical Endocrinology</em> and endorsed by the Association for Clinical Biochemistry and Laboratory Medicine, the BTF, the RCP and the SOE. The full statement is attached and available online at:</p><br /><p><a href="http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full</a></p><br /><p>Regarding international guidance and harmonisation on approaches to testing, the existing United Kingdom guidelines have now been supported by new guidance published in the United States of America which draws on the latest research and available evidence on the management of the condition. The USA guidance also includes a section on the ethics of prescribing thyroid hormone combination therapies when the potential long-term harmful effects are not known.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name Okosieme_et_al-2015-Clinical_Endocrinology.pdf more like this
star this property title Clinical Endocrinology paper more like this
2
star this property file name the-diagnosis-and-management-of-primary-hypothyroidism-revised-statement-14-june-2011_2.pdf more like this
star this property title Royal College of Physicians guidance more like this
3
star this property file name TFT_guideline_final_version_July_2006.pdf more like this
star this property title UK Guidelines Thyroid Function Tests more like this
star this property grouped question UIN
HL2640 more like this
HL2641 more like this
HL2642 more like this
star this property question first answered
less than 2015-10-27T17:53:42.837Zmore like thismore than 2015-10-27T17:53:42.837Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
457
star this property label Biography information for Lord Pendry more like this
421269
unstar this property registered interest false remove filter
star this property date less than 2015-10-14more like thismore than 2015-10-14
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Hypothyroidism more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether there are any plans to amend the diagnosis of hypothyroidism, which under current guidance is based solely on a blood test. more like this
star this property tabling member printed
Lord Pendry more like this
unstar this property uin HL2640 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-10-27more like thismore than 2015-10-27
star this property answer text <p>A blood test measuring hormone levels is the only accurate way to find out if there is a thyroid problem.</p><br /><p>Best practice on the identification and management of hypothyroidism has been set out by the Royal College of Physicians (RCP) in its guidance, <em>The Diagnosis and Management of Primary Hypothyroidism</em>, first published in 2008. The guidance, which is attached, was developed on behalf of key organisations, including the British Thyroid Association (BTA), the British Thyroid Foundation (BTF) and the Society for Endocrinology (SOE), and is endorsed by the Royal College of General Practitioners. A copy of the UK Guidelines is attached.</p><br /><p>The RCP guidance sets out that the only validated method of testing thyroid function is through a blood sample, which must include measurement of the levels of thyroid‐stimulating hormone (TSH) and free thyroxine (FT4) in serum, as recommended in the <em>UK Guidelines for the Use of Thyroid Function Tests</em> published by the BTA.</p><br /><p>The RCP guidelines set out that overwhelming evidence supports the use of thyroxine hormone replacement (T4 or tetra-iodothyronine) alone in the treatment of hypothyroidism, with this usually being prescribed as levothyroxine. However, this does not prevent clinicians considering other forms of thyroid hormone replacement if appropriate.</p><p>The guidance remains up-to-date and a statement from the BTA Executive Committee supporting the existing guidelines was published in May 2015 in <em>Clinical Endocrinology</em> and endorsed by the Association for Clinical Biochemistry and Laboratory Medicine, the BTF, the RCP and the SOE. The full statement is attached and available online at:</p><br /><p><a href="http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full</a></p><br /><p>Regarding international guidance and harmonisation on approaches to testing, the existing United Kingdom guidelines have now been supported by new guidance published in the United States of America which draws on the latest research and available evidence on the management of the condition. The USA guidance also includes a section on the ethics of prescribing thyroid hormone combination therapies when the potential long-term harmful effects are not known.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name Okosieme_et_al-2015-Clinical_Endocrinology.pdf more like this
star this property title Clinical Endocrinology paper more like this
2
star this property file name the-diagnosis-and-management-of-primary-hypothyroidism-revised-statement-14-june-2011_2.pdf more like this
star this property title Royal College of Physicians guidance more like this
3
star this property file name TFT_guideline_final_version_July_2006.pdf more like this
star this property title UK Guidelines Thyroid Function Tests more like this
star this property grouped question UIN
HL2639 more like this
HL2641 more like this
HL2642 more like this
star this property question first answered
less than 2015-10-27T17:53:42.923Zmore like thismore than 2015-10-27T17:53:42.923Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
457
star this property label Biography information for Lord Pendry more like this
421270
unstar this property registered interest false remove filter
star this property date less than 2015-10-14more like thismore than 2015-10-14
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Hypothyroidism more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what progress is being made on the initiative to achieve greater harmonisation on approaches to diagnosing hypothyroidism internationally. more like this
star this property tabling member printed
Lord Pendry more like this
unstar this property uin HL2641 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-10-27more like thismore than 2015-10-27
star this property answer text <p>A blood test measuring hormone levels is the only accurate way to find out if there is a thyroid problem.</p><br /><p>Best practice on the identification and management of hypothyroidism has been set out by the Royal College of Physicians (RCP) in its guidance, <em>The Diagnosis and Management of Primary Hypothyroidism</em>, first published in 2008. The guidance, which is attached, was developed on behalf of key organisations, including the British Thyroid Association (BTA), the British Thyroid Foundation (BTF) and the Society for Endocrinology (SOE), and is endorsed by the Royal College of General Practitioners. A copy of the UK Guidelines is attached.</p><br /><p>The RCP guidance sets out that the only validated method of testing thyroid function is through a blood sample, which must include measurement of the levels of thyroid‐stimulating hormone (TSH) and free thyroxine (FT4) in serum, as recommended in the <em>UK Guidelines for the Use of Thyroid Function Tests</em> published by the BTA.</p><br /><p>The RCP guidelines set out that overwhelming evidence supports the use of thyroxine hormone replacement (T4 or tetra-iodothyronine) alone in the treatment of hypothyroidism, with this usually being prescribed as levothyroxine. However, this does not prevent clinicians considering other forms of thyroid hormone replacement if appropriate.</p><p>The guidance remains up-to-date and a statement from the BTA Executive Committee supporting the existing guidelines was published in May 2015 in <em>Clinical Endocrinology</em> and endorsed by the Association for Clinical Biochemistry and Laboratory Medicine, the BTF, the RCP and the SOE. The full statement is attached and available online at:</p><br /><p><a href="http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full</a></p><br /><p>Regarding international guidance and harmonisation on approaches to testing, the existing United Kingdom guidelines have now been supported by new guidance published in the United States of America which draws on the latest research and available evidence on the management of the condition. The USA guidance also includes a section on the ethics of prescribing thyroid hormone combination therapies when the potential long-term harmful effects are not known.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name Okosieme_et_al-2015-Clinical_Endocrinology.pdf more like this
star this property title Clinical Endocrinology paper more like this
2
star this property file name the-diagnosis-and-management-of-primary-hypothyroidism-revised-statement-14-june-2011_2.pdf more like this
star this property title Royal College of Physicians guidance more like this
3
star this property file name TFT_guideline_final_version_July_2006.pdf more like this
star this property title UK Guidelines Thyroid Function Tests more like this
star this property grouped question UIN
HL2639 more like this
HL2640 more like this
HL2642 more like this
star this property question first answered
less than 2015-10-27T17:53:43.017Zmore like thismore than 2015-10-27T17:53:43.017Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
457
star this property label Biography information for Lord Pendry more like this
421271
unstar this property registered interest false remove filter
star this property date less than 2015-10-14more like thismore than 2015-10-14
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Hypothyroidism more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether there are any plans to amend the treatment of hypothyroidism by including thyroid hormone combination therapies other than treatment by levothyroxine in the standard of care. more like this
star this property tabling member printed
Lord Pendry more like this
unstar this property uin HL2642 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-10-27more like thismore than 2015-10-27
star this property answer text <p>A blood test measuring hormone levels is the only accurate way to find out if there is a thyroid problem.</p><br /><p>Best practice on the identification and management of hypothyroidism has been set out by the Royal College of Physicians (RCP) in its guidance, <em>The Diagnosis and Management of Primary Hypothyroidism</em>, first published in 2008. The guidance, which is attached, was developed on behalf of key organisations, including the British Thyroid Association (BTA), the British Thyroid Foundation (BTF) and the Society for Endocrinology (SOE), and is endorsed by the Royal College of General Practitioners. A copy of the UK Guidelines is attached.</p><br /><p>The RCP guidance sets out that the only validated method of testing thyroid function is through a blood sample, which must include measurement of the levels of thyroid‐stimulating hormone (TSH) and free thyroxine (FT4) in serum, as recommended in the <em>UK Guidelines for the Use of Thyroid Function Tests</em> published by the BTA.</p><br /><p>The RCP guidelines set out that overwhelming evidence supports the use of thyroxine hormone replacement (T4 or tetra-iodothyronine) alone in the treatment of hypothyroidism, with this usually being prescribed as levothyroxine. However, this does not prevent clinicians considering other forms of thyroid hormone replacement if appropriate.</p><p>The guidance remains up-to-date and a statement from the BTA Executive Committee supporting the existing guidelines was published in May 2015 in <em>Clinical Endocrinology</em> and endorsed by the Association for Clinical Biochemistry and Laboratory Medicine, the BTF, the RCP and the SOE. The full statement is attached and available online at:</p><br /><p><a href="http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full</a></p><br /><p>Regarding international guidance and harmonisation on approaches to testing, the existing United Kingdom guidelines have now been supported by new guidance published in the United States of America which draws on the latest research and available evidence on the management of the condition. The USA guidance also includes a section on the ethics of prescribing thyroid hormone combination therapies when the potential long-term harmful effects are not known.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name Okosieme_et_al-2015-Clinical_Endocrinology.pdf more like this
star this property title Clinical Endocrinology paper more like this
2
star this property file name the-diagnosis-and-management-of-primary-hypothyroidism-revised-statement-14-june-2011_2.pdf more like this
star this property title Royal College of Physicians guidance more like this
3
star this property file name TFT_guideline_final_version_July_2006.pdf more like this
star this property title UK Guidelines Thyroid Function Tests more like this
star this property grouped question UIN
HL2639 more like this
HL2640 more like this
HL2641 more like this
star this property question first answered
less than 2015-10-27T17:53:43.093Zmore like thismore than 2015-10-27T17:53:43.093Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
457
star this property label Biography information for Lord Pendry more like this
425861
unstar this property registered interest false remove filter
star this property date less than 2015-11-03more like thismore than 2015-11-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Diagnosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what action they are taking to improve rates of early diagnosis of cancer. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
unstar this property uin HL3259 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-11-12more like thismore than 2015-11-12
star this property answer text <p>Improving early diagnosis of cancer is a priority for this Government. We will continue to work with NHS England, Public Health England and other partners to achieve early diagnosis through improved screening programmes, Be Clear on Cancer campaigns to raise awareness of signs and symptoms of cancer to encourage people with signs and symptoms to present promptly to their general practitioner (GP), and help for GPs to refer more accurately.</p><br /><p>We have committed to implementing recommendation 24 of the Independent Cancer Taskforce’s report that by 2020, everyone referred with a suspicion of cancer will receive either a definitive diagnosis or the all-clear within four weeks. NHS England is working with partners across the health system to consider how best to take this forward. A copy of the Taskforce’s report <em>Achieving World-Class Outcomes: A Strategy for England 2015-2020, </em>is attached.</p><p>NHS England has launched a major early diagnosis programme, Accelerate, Co-ordinate, Evaluate (ACE), working jointly with Cancer Research UK and Macmillan Cancer Support to test new innovative approaches to identifying cancer more quickly. Outputs from the first wave of test sites, which commenced in April 2015, will be delivered on a phased basis, with the majority falling between September 2015 and December 2016. It is expected that ACE Wave 1 evaluation will be complete by mid-2017. An ACE Wave 2 is being planned.</p><br /><p>In June this year, the National Institute for Health and Care Excellence published an updated guideline ‘Suspected cancer: recognition and referral’. The guideline focuses on key symptoms, to make it easier to use and will continue to support GPs to identify patients with signs and symptoms of suspected cancer, and urgently refer them as appropriate. The guideline recommends a lower referral threshold for urgent referrals where cancer is suspected. A copy of the guideline is also attached.</p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf more like this
star this property title Achieving World Class Outcomes more like this
2
star this property file name suspected-cancer-recognition-and-referral-1837268071621.pdf more like this
star this property title Suspected cancer more like this
star this property question first answered
less than 2015-11-12T13:06:02.387Zmore like thismore than 2015-11-12T13:06:02.387Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
2024
star this property label Biography information for Lord Hunt of Kings Heath more like this
637284
unstar this property registered interest false remove filter
star this property date less than 2016-11-15more like thismore than 2016-11-15
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Health Services: Travellers more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 8 November (HL2865), what steps have been taken to encourage joined up working by local authorities, the National Health Service and responsible health agencies, and local public health services to improve the health outcomes of Gypsies and Travellers. more like this
star this property tabling member printed
Baroness Hodgson of Abinger more like this
unstar this property uin HL3209 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-11-24more like thismore than 2016-11-24
star this property answer text <p>The <em>NHS Five Year Forward View</em> (2014) sets out the ambition to improve the nation’s health and reduce inequalities, including among the most vulnerable groups. Through the inequality duties introduced through the 2012 Health and Social Care Act, local areas must have regard to inequalities in access to, and the outcomes from, National Health Service services in developing their plans. Clinical commissioning groups (CCGs), health and wellbeing boards and the rest of the local health system work together to undertake joint strategic needs assessments of local health needs and develop strategic plans, working with key stakeholders to deliver outcomes and reduce health inequalities. <strong> </strong></p><p> </p><p>All CCGs are provided with local and national data from Public Health England and NHS England to support the planning and commissioning process. These tools help to identify differences in access to services and health outcomes across the local population, including among vulnerable groups. For example, on-line resources available to local areas include Commissioning for Value Packs, the NHS Atlas of Variation in Healthcare, and the Marmot indicator local authority profiles.</p><p> </p><p>Guidance on addressing the health needs of vulnerable groups including Gypsies and Travellers was developed under the DH-sponsored inclusion health programme. It included <em>Inclusion of Gypsy Traveller health needs in Joint Strategic Needs Assessments: A review</em>, a report compiled by Friends, Families and Travellers (2015), <em>Standards for commissioners and service providers</em>, by the Faculty for Homeless and Inclusion Health (2013) and <em>Improving access to health care for Gypsies and Travellers, homeless people and sex workers</em>, by Royal College of General Practitioners (2013). Copies of these documents are attached. NHS England published guidance for the service on the rights of vulnerable groups in registering with GPs to reduce the risk of exacerbating health inequalities for vulnerable groups, <em>Patient Registration: Standard Operating Principles for Primary Medical Care (General Practice)</em>, NHS England, 2015. A copy has been placed in the library.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name Improving access to healthcare.pdf more like this
star this property title Improving access to healthcare more like this
2
star this property file name standards for commissioners.pdf more like this
star this property title Standards for commissioners more like this
3
star this property file name Inclusion of Gypsy Traveller health needs.pdf more like this
star this property title Inclusion of Gypsy Traveller health needs more like this
star this property question first answered
less than 2016-11-24T15:22:58.927Zmore like thismore than 2016-11-24T15:22:58.927Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
4301
star this property label Biography information for Baroness Hodgson of Abinger more like this
422466
unstar this property registered interest false remove filter
star this property date less than 2015-10-20more like thismore than 2015-10-20
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Hepatitis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government, to date, how many patients have commenced treatment under NHS England's commissioning policy for the treatment of cirrhosis in adults with hepatitis C, and how much that commissioning policy has cost. more like this
star this property tabling member printed
Baroness Masham of Ilton more like this
unstar this property uin HL2791 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-11-02more like thismore than 2015-11-02
star this property answer text <p>NHS England has invested in two policies enabling access to some of the new treatments (in advance of the publication of National Institute for Health and Care Excellence technology appraisals) for patients with hepatitis C with the greatest clinical need.</p><p>NHS England’s Interim Clinical Commissioning Policy Statement of April 2014 provided an Early Access Scheme for around 1,000 patients with decompensated cirrhosis. Then in June 2015, NHS England extended that policy so the next group of patients with the greatest clinical need, those with cirrhosis, could also benefit from the new Direct Acting Antivirals. A copy of both of these policies has been attached.</p><p>Between publication of the cirrhosis policy in June and 19 October, NHS England received over 1,900 notifications of decisions to treat under the policy. These notifications are submitted by treating clinicians and confirm that patients meet the policy criteria.</p><p>In order to confirm the actual cost of this policy, NHS England needs to complete a process of validating treatment notifications against actual trust reported activity and invoicing data on dispensed drugs. These data sources are submitted at different times and so an accurate assessment of the cost of the policy to date will not be able to be possible until the end of the year. Any data shared on the cost of the policy will need to observe commercial in confidence pricing agreements.</p><p>Based on preliminary modelling, NHS England set aside £190 million in 2015-16 for the treatment of hepatitis C.</p>
star this property answering member printed Lord Prior of Brampton more like this
star this property attachment
1
star this property file name sofosbuvir-pol-stat.pdf more like this
star this property title Sofosbuvir Policy Statement more like this
2
star this property file name hep-c-cirrhosis-polcy-statmnt-0615.pdf more like this
star this property title Hep C Policy Statement more like this
star this property question first answered
less than 2015-11-02T16:47:03.393Zmore like thismore than 2015-11-02T16:47:03.393Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton remove filter
star this property tabling member
1850
star this property label Biography information for Baroness Masham of Ilton more like this